Terms: = Breast cancer AND FEV, Pet-1, 54738, ENSG00000163497, PET-1, HSRNAFEV AND Diagnosis
3 results:
1. Incidence and risk factors of cancer in individuals with cystic fibrosis in the UK; a case-control study.
Archangelidi O; Cullinan P; Simmonds NJ; Mentzakis E; Peckham D; Bilton D; Carr SB
J Cyst Fibros; 2022 Mar; 21(2):302-308. PubMed ID: 34348871
[TBL] [Abstract] [Full Text] [Related]
2. Early and delayed prediction of axillary lymph node neoadjuvant response by (18)F-FDG PET/CT in patients with locally advanced breast cancer.
García Vicente AM; Soriano Castrejón Á; León Martín A; Relea Calatayud F; Muñoz Sánchez Mdel M; Cruz Mora MÁ; Jiménez Londoño GA; Espinosa Aunión R
Eur J Nucl Med Mol Imaging; 2014 Jul; 41(7):1309-18. PubMed ID: 24744045
[TBL] [Abstract] [Full Text] [Related]
3. Dual-time-point [18F]-FDG PET/CT in the diagnostic evaluation of suspicious breast lesions.
Caprio MG; Cangiano A; Imbriaco M; Soscia F; Di Martino G; Farina A; Avitabile G; Pace L; Forestieri P; Salvatore M
Radiol Med; 2010 Mar; 115(2):215-24. PubMed ID: 20017002
[TBL] [Abstract] [Full Text] [Related]
